Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW:FSE) announced the launch of a new clinical research program that will evaluate the use of the drug Ifenprodil (NP-120) in treating pancreatic cancer. The announcement followed the… Read More
VANCOUVER, BC – Incisive Genetics Inc. (“IG”), a privately held biotech company specializing in the research and development of a novel non-viral delivery platform for targeted CRISPR-based gene therapies, announced… Read More
Vancouver, BC– iCo Therapeutics Inc. (“iCo” or the “Company”) (TSXV: iCo) (OTCQB: iCoTF) is pleased to announce that the Company has received formal conditional approval from the TSX Venture Exchange… Read More
VANCOUVER, BC–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that the Company will present at the upcoming Ladenburg Thalmann Healthcare Conference on July 14,… Read More
VANCOUVER, BC –(BUSINESS WIRE)–SaNOtize Research and Development Corporation (“SaNOtize” or “the Company”) today announced that Enovid, SaNOtize’s Nitric Oxide Nasal Spray (NONS) that protects from viruses and was shown to… Read More
